Loading...
OTCM
RXEI
Market cap1kUSD
Nov 03, Last price  
0.00USD
Name

RXElite Inc

Chart & Performance

D1W1MN
OTCM:RXEI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
3m
+138.97%
835,076966,4901,176,5382,811,596
Net income
-17m
L
-34,300-35,90493,986-17,165,275
CFO
-13m
L
13,28871,793-13,366,194

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

RxElite, Inc. is a pharmaceutical company that specializes in the development, production, and commercialization of generic prescription drugs, particularly within specialty markets. Its diverse product portfolio encompasses Sterile Liquid Dose offerings, such as generic ophthalmic solutions (available in both unit-dose and multi-dose formats), sterile unit-dose respiratory inhalation products, and various injectable medications. Beyond its finished drug products, the company, operating through its subsidiaries, also serves as a manufacturer of active pharmaceutical ingredients (APIs) for other pharmaceutical entities across the United States, Europe, and Asia. RxElite's extensive customer base includes institutional clients like hospitals and hospital group purchasing organizations, national and regional wholesale distributors, major direct retail pharmacy chains, home healthcare providers, and various outpatient surgery centers and ambulatory care clinics. The company maintains strategic alliances with industry partners such as Stason Pharmaceuticals, Inc., Alkem Laboratories Limited, and Zach Systems S.p.A. Headquartered in Meridian, Idaho, RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd.
URL
IPO date
Jul 23, 2007
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show